Associate Director, US Empasiprubart Marketing
argenx
About this role
A Director at argenx leads the strategic launch and commercialization of empasiprubart for Multifocal Motor Neuropathy (MMN). The role focuses on market readiness, HCP engagement, and cross-functional execution to deliver a transformative therapy for patients.
Skills
Qualifications
About argenx
argenx.comReaching Patients Through Immunology Innovation
Recent company news
Seeking AlphaArgenx SE: Excellent Company, Premium Valuation (NASDAQ:ARGX)
2 days ago
Yahoo FinanceAnalysts Express Mixed Opinion on Argenx SE (ARGX) Stock
4 days ago
Finviz - Stock ScreenerArgenx (ARGX) 2025 Net Product Sales Rise 90% to $4.2B as First Annual Profit Reached
3 days ago
Fierce PharmaOMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago
Investing.comDeutsche Bank upgrades argenx stock to Buy on valuation appeal
1 day ago
About argenx
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for argenx.
Salary
$168k – $231k
per year